AssayIndex
Reports by quarter

Reports submitted in 2025-Q1

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.28 %updated 30 Jul 2026
0357010592.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=096.25–96.50 %: n=096.50–96.75 %: n=096.75–97.00 %: n=297.00–97.25 %: n=497.25–97.50 %: n=297.50–97.75 %: n=597.75–98.00 %: n=2198.00–98.25 %: n=3898.25–98.50 %: n=7098.50–98.75 %: n=4998.75–99.00 %: n=9699.00–99.25 %: n=7199.25–99.50 %: n=9699.50–99.75 %: n=8699.75–100.00 %: n=124median 99.14 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2025-Q1. n=664, median 99.14 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-018918CJC-1295 with DACTFSTFS-{CAT}-9795PeptideMeter2025-Q198.843.69—Buyer-sourced2MARGINAL
AX-2025-018829BPC-157FGPFGP-2409-Y8596VendorInvestigate2025-Q199.845.4095.4Buyer-sourced0PASS
AX-2025-020836IpamorelinCPCCPC-2503-J1794Medutest2025-Q198.556.84—Supplier-supplied0FAIL
AX-2025-018642TirzepatideQSCQSC-2408-T5296Janoshik2025-Q199.915.5798.7Buyer-sourced0PASS
AX-2025-020944BPC-157WXTWXT-2501-J3079PeptideMeter2025-Q198.555.96—Laboratory-retained0PASS
AX-2025-020792TB-500CPCCPC-2408-B9995Nordanalyt2025-Q198.454.6495.9Buyer-sourced0FAIL
AX-2025-020600SermorelinSSASSA-2409-X7161Janoshik2025-Q198.554.96105.3Buyer-sourced0PASS
AX-2025-019646GHRP-2TFCTFC-2502-D2333Janoshik2025-Q199.825.7693.2Buyer-sourced0PASS
AX-2025-021222BPC-157PPGPPG-2412-N7907Nordanalyt2025-Q199.903.7291.3Buyer-sourced0PASS
AX-2025-020902MK-677 (Ibutamoren mesylate)WXTWXT-2502-F2050Medutest2025-Q199.724.14106.8Buyer-sourced0FAIL
AX-2025-018670TirzepatideQSCQSC-2410-R5814VendorInvestigate2025-Q199.394.86102.2Buyer-sourced0PASS
AX-2025-019713L-Glutathione (reduced)HomopeptideHOMO-2408-R3237Janoshik2025-Q199.319.6597.4Buyer-sourced1MARGINAL
AX-2025-019645GHRP-2TFCTFC-2502-D2333Kestrel2025-Q199.934.78—Buyer-sourced0PASS
AX-2025-018999HexarelinASYASY-{CAT}-1786Janoshik2025-Q199.754.2293.1Buyer-sourced0PASS
AX-2025-018676TirzepatideQSCQSC-2410-R5814Nordanalyt2025-Q199.205.3199.5Buyer-sourced0PASS
AX-2025-021174SS-31 (Elamipretide)PPGPPG-2411-D6795Nordanalyt2025-Q199.835.37—Buyer-sourced0PASS
AX-2025-018518SemaglutideWWBWWB-2410-J3284Janoshik2025-Q199.363.6596.8Buyer-sourced0PASS
AX-2025-021022PT-141 (Bremelanotide)WXTWXT-2411-R3766Janoshik2025-Q198.635.79—Buyer-sourced0PASS
AX-2025-019611GHRP-2TFCTFC-2411-A2083PeptideMeter2025-Q199.932.10—Buyer-sourced0PASS
AX-2025-018469TirzepatideWWBWWB-2502-U2990Kestrel2025-Q199.252.49—Buyer-sourced1MARGINAL
AX-2025-019119VilonGSPGSP-2411-J3700Janoshik2025-Q199.366.2489.5Buyer-sourced1FAIL
AX-2025-020483LiraglutideKPKP-2502-E5631VendorInvestigate2025-Q198.986.2793.3Buyer-sourced0PASS
AX-2025-021019PT-141 (Bremelanotide)WXTWXT-2411-R3766Medutest2025-Q198.414.9494.1Buyer-sourced0FAIL
AX-2025-020290BPC-157GGPepsGGPE-2502-S2559Medutest2025-Q199.062.82—Buyer-sourced0PASS
AX-2025-020063P21SWBSWB-2408-T8372Kestrel2025-Q199.028.2398.6Buyer-sourced0PASS
AX-2025-019371GHRP-2HYBHYB-2501-R7240Nordanalyt2025-Q199.934.21—Buyer-sourced0PASS
AX-2025-019187PEG-MGFSinoPepSNP-2411-S4752Janoshik2025-Q197.174.55—Buyer-sourced0PASS
AX-2025-019044N-Acetyl Semax AmideASYASY-{CAT}-2147Janoshik2025-Q199.868.49—Buyer-sourced0PASS
AX-2025-018835CJC-1295 (no DAC)FGPFGP-2503-P8516Janoshik2025-Q199.536.5692.8Buyer-sourced0PASS
AX-2025-020833IpamorelinCPCCPC-2503-J1794Janoshik2025-Q197.956.42105.9Buyer-sourced0FAIL
AX-2025-020713IGF-1 LR3SGNSGN-2409-D9295PeptideMeter2025-Q198.385.4297.0Buyer-sourced0PASS
AX-2025-020517MOTS-cSSASSA-2501-M6154VendorInvestigate2025-Q198.213.21103.0Buyer-sourced0PASS
AX-2025-020508MOTS-cSSASSA-2501-M6154Medutest2025-Q198.303.1097.1Supplier-supplied0PASS
AX-2025-019062MK-677 (Ibutamoren mesylate)GSPGSP-2501-R2783Medutest2025-Q199.855.91—Buyer-sourced0FAIL
AX-2025-018957TirzepatideASYASY-{CAT}-1244PeptideMeter2025-Q198.375.2989.3Buyer-sourced1MARGINAL
AX-2025-018843PT-141 (Bremelanotide)FGPFGP-2409-W9076PeptideMeter2025-Q199.585.25—Buyer-sourced0PASS
AX-2025-018747CJC-1295 (no DAC)QSCQSC-2411-D7855VendorInvestigate2025-Q198.884.3391.5Buyer-sourced0PASS
AX-2025-020837IpamorelinCPCCPC-2503-J1794Medutest2025-Q198.256.55—Buyer-sourced0FAIL
AX-2025-019805L-Glutathione (reduced)HomopeptideHOMO-2501-D4371Janoshik2025-Q199.718.4089.3Buyer-sourced1MARGINAL
AX-2025-019492KPVJEEPJEEP-2410-C8600Janoshik2025-Q199.935.0996.5Laboratory-retained0PASS